Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma

NCT00978471 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT00978471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00978471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
October 29, 2018
Enrollment
44 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma